LTA rs1800924: What Your Genotype Means
The rs1800924 variant is a single nucleotide polymorphism located within the LTA gene, which encodes a protein involved in immune and inflammatory responses. Research has investigated its potential association with vascular health, specifically regarding the risk of myocardial infarction and ischemic stroke.
What each genotype means
Typical LTA expression
This genotype represents the common Thr26 allele of the LTA gene. Research into this variant has produced mixed results regarding its role in cardiovascular health, and it is not considered a diagnostic marker for disease risk.
This is a common genotype, though its prevalence varies significantly by ancestry, with the A allele being more frequent in many populations.
Heterozygous LTA variant
You carry one copy of the Thr26 allele and one copy of the Asn26 variant. Studies have investigated whether this variant influences inflammatory responses and cardiovascular risk, but findings remain inconsistent across different ethnic groups and clinical cohorts.
This heterozygous genotype is frequently observed in global populations, reflecting the common nature of the G allele.
Increased LTA variant presence
You carry two copies of the Asn26 variant. Some studies have suggested an association between this genotype and an increased risk of myocardial infarction or coronary atherosclerosis, particularly in specific populations, while other studies have found no significant link. This variant is not a standalone predictor of heart health, and you should discuss any cardiovascular concerns with your clinician.
The G allele is common, with a minor allele frequency of approximately 0.30-0.40 in European and East Asian cohorts.
Understanding the rs1800924 Variant
The rs1800924 variant is a specific change in the DNA sequence of the LTA gene, often referred to in scientific literature as the Thr26Asn polymorphism. This variant represents a single nucleotide change that results in an amino acid substitution in the lymphotoxin-alpha protein. Located on chromosome 6 within the major histocompatibility complex (MHC) region, this gene is situated in a highly complex area of the human genome known for its role in immune system regulation. Because this region is dense with genes related to inflammation and immune function, researchers have long studied variations here to understand how they might influence susceptibility to various chronic conditions. While rs1800924 is a well-documented marker, it is important to recognize that it is just one of many variations within the LTA gene, and its presence does not function in isolation from other genetic or environmental factors.
The Role of the LTA Gene
The LTA gene provides instructions for producing a protein called lymphotoxin-alpha. This protein is a member of the tumor necrosis factor (TNF) superfamily, a group of cytokines that play critical roles in the body's inflammatory and immune responses. Lymphotoxin-alpha is primarily produced by lymphocytes, a type of white blood cell, and it functions by forming complexes that help regulate cell survival, apoptosis, and the development of lymphoid tissues. Beyond its role in the immune system, lymphotoxin-alpha is involved in modulating vascular inflammatory tone. Because inflammation is a key component in the development of atherosclerosis—the buildup of fats and cholesterol in artery walls—the LTA gene has become a focus for researchers studying cardiovascular health. By influencing how the body manages inflammatory signals, variations in this gene may theoretically alter the body's response to vascular stress.
Research and Evidence Strength
The association between rs1800924 and cardiovascular outcomes has been the subject of numerous studies, though the evidence is considered limited and sometimes mixed. Early research identified potential links between this variant and an increased risk of myocardial infarction and ischemic stroke, suggesting that the Asn allele might influence the severity of coronary atherosclerosis. However, large-scale genome-wide association studies (GWAS) have often yielded complex results, with some studies finding significant correlations in specific populations while others have failed to replicate these findings consistently. It is essential to understand that genetic associations are statistical in nature and do not imply a direct cause-and-effect relationship. The influence of this variant is likely modulated by a wide array of other genetic markers and lifestyle factors, such as diet, exercise, and smoking status, which play a much larger role in overall cardiovascular health.
What This Information Means for You
Learning about your genotype for rs1800924 provides a glimpse into one small piece of your genetic makeup, but it should not be used to predict your personal health outcomes. Because the evidence linking this variant to disease is limited and inconsistent across different populations, it is not currently used as a diagnostic tool in clinical practice. You cannot change your genotype, but you can manage the modifiable risk factors that have a proven impact on heart health. If you are concerned about your cardiovascular risk, the most effective approach is to consult with a healthcare professional who can evaluate your family history, blood pressure, cholesterol levels, and other established clinical markers. Never use genetic information to make decisions about medications or lifestyle changes without first discussing them with your doctor or a qualified pharmacist.
How common is this variant?
The minor allele frequency for rs1800924 is approximately 0.30 to 0.40 in both European and East Asian populations, making it a relatively common variant.
Frequently asked questions
Is rs1800924 a diagnostic test for heart disease?
No, rs1800924 is not a diagnostic test. It is a genetic marker that has shown statistical associations with cardiovascular risk in some studies, but it is not used by clinicians to diagnose heart disease.
Can I change my risk associated with this variant?
While you cannot change your genetic code, you can manage your cardiovascular health through lifestyle choices. Factors like diet, physical activity, and smoking cessation have a much larger impact on heart health than this specific variant.
Why do different studies show different results for this SNP?
Genetic associations can vary due to differences in study design, sample sizes, and the genetic backgrounds of the populations being studied. This is why the evidence for many common variants remains limited or mixed.
Should I take medication based on my LTA genotype?
No. You should never start, stop, or change any medication based on your genetic results. Always discuss your health concerns and any genetic information with your doctor or pharmacist.
Sources & further reading
Educational information only, last refreshed 10/16/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs1800924?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29